Hyun-ju Lee

Daegu, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

The CDK4/6 inhibitor abemaciclib attenuates cognitive impairment and neuroinflammation via DYRK1A in human tau transgenic mice.

The CDK4/6 inhibitor abemaciclib attenuates cognitive impairment and neuroinflammation via DYRK1A in human tau transgenic mice.

Journal: Molecular brain

Published: March 12, 2026

Color Dependence of OLED Phototherapy for Cognitive Function and Beta-Amyloid Reduction through ADAM17 and BACE1.

Color Dependence of OLED Phototherapy for Cognitive Function and Beta-Amyloid Reduction through ADAM17 and BACE1.

Journal: ACS biomaterials science & engineering

Published: October 25, 2025

AI-enabled digital phenotyping for Alzheimer's disease: a review of multimodal sensor integration and symptom trajectories.

AI-enabled digital phenotyping for Alzheimer's disease: a review of multimodal sensor integration and symptom trajectories.

Journal: Alzheimer's research & therapy

Published: October 23, 2025

The insulin receptor inhibitor BMS-754807 alleviates neuroinflammation and Alzheimer's disease pathologies across human cellular and mouse models.

The insulin receptor inhibitor BMS-754807 alleviates neuroinflammation and Alzheimer's disease pathologies across human cellular and mouse models.

Journal: Journal of neuroinflammation

Published: September 17, 2025

Epigenetic regulation of the glucocorticoid receptor gene through methylation is linked to post-traumatic stress disorder.

Epigenetic regulation of the glucocorticoid receptor gene through methylation is linked to post-traumatic stress disorder.

Journal: Scientific reports

Published: August 19, 2025

A selective agonist of the prostacyclin receptor alleviates microglial and astroglial neuroinflammatory responses through P38 and NLRP3.

A selective agonist of the prostacyclin receptor alleviates microglial and astroglial neuroinflammatory responses through P38 and NLRP3.

Journal: Frontiers in immunology

Published: July 11, 2025

Genetic knockdown of DYRK1A attenuates cognitive impairment, Aβ pathology, tauopathy and neuroinflammatory responses in mouse models of AD.

Genetic knockdown of DYRK1A attenuates cognitive impairment, Aβ pathology, tauopathy and neuroinflammatory responses in mouse models of AD.

Journal: Frontiers in immunology

Published: July 08, 2025

Chronic oral administration of ibrutinib prevents long-term memory deficits and reduces AD pathology and neuroinflammatory responses in a mouse model of AD.

Chronic oral administration of ibrutinib prevents long-term memory deficits and reduces AD pathology and neuroinflammatory responses in a mouse model of AD.

Journal: Molecular brain

Published: March 03, 2025

Erdafitinib diminishes LPS-mediated neuroinflammatory responses through NLRP3 in wild-type mice.

Erdafitinib diminishes LPS-mediated neuroinflammatory responses through NLRP3 in wild-type mice.

Journal: Frontiers in pharmacology

Published: February 07, 2025

Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives.

Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives.

Journal: Medicinal research reviews

Published: February 05, 2025

Current Status and Future Directions in the Development of Digital Therapeutic Interventions for Neurodevelopmental Disorders.

Current Status and Future Directions in the Development of Digital Therapeutic Interventions for Neurodevelopmental Disorders.

Journal: Clinical pharmacology and therapeutics

Published: July 18, 2024

Felodipine attenuates neuroinflammatory responses and tau hyperphosphorylation through JNK/P38 signaling in tau-overexpressing AD mice.

Felodipine attenuates neuroinflammatory responses and tau hyperphosphorylation through JNK/P38 signaling in tau-overexpressing AD mice.

Journal: Molecular brain

Published: July 11, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026